Results 191 to 200 of about 9,826,201 (402)
Clinical pharmacology of cephalexin administered by intravenous injection [PDF]
Jamie A. Davies, James Holt
openalex +1 more source
Post‐surgical tumor therapy struggles with recurrence and inefficient healing. Anti‐tumor DNA aptamer functionalized gelatin hydrogels, Apt‐GelMA, simultaneously address both issues by suppressing tumor regrowth via targeted tumor cell inhibition and enhancing wound healing through improved cell adhesion and migration. Their biocompatibility, stability,
Tianyue Li+11 more
wiley +1 more source
Clinical Pharmacology in the NHS [PDF]
P N Bennett+2 more
openaire +4 more sources
Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS). [PDF]
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants develop after intrauterine maternal drug exposure. All infants with documented in utero opioid exposure, or a high pre-test probability of exposure should have ...
Kraft, W. K.+2 more
core +1 more source
This review highlights emerging bioengineering strategies for treating neointimal hyperplasia in the peripheral vasculature, focusing on approaches that promote re‐endothelialization, modulate smooth muscle cell phenotype, reduce inflammation, mitigate oxidative stress, and optimize biomechanical compliance.
Nikita Wilson John+5 more
wiley +1 more source
Obstetric Therapeutics. Clinical Pharmacology and Therapeutics in Obstetric Practice [PDF]
openalex +1 more source
This study presents a novel implantable drug delivery systemwith a biodegradable poly(caprolactone) membrane and compressed drug core forsustained release. These implantable devices deliver risperidone in vitro for 170 days and in vivo for 49 days in rats, showing promise for chronic conditions like schizophrenia.
Linlin Li+9 more
wiley +1 more source
Commentary, The Washington Conference on Clinical Pharmacology [PDF]
Edward A. Carr
openalex +1 more source